Prokidney (PROK) Cash & Equivalents (2021 - 2026)
Prokidney (PROK) reported Cash & Equivalents of $181.56 million for Q2 2026, up 113.8% from $84.94 million a year earlier and up 78.2% from the prior quarter.
Powered by 
Analysis
Prokidney (PROK) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Prokidney posted Cash & Equivalents of $108.54 million, up 9.5% from FY2024.
- Cash & Equivalents has a four-year compound annual growth rate of 51.6% (FY2021 to FY2025).
- By year, Cash & Equivalents came in at $99.12 million in FY2024 (+63.4%), $60.65 million in FY2023 (-87.6%), $490.25 million in FY2022 and $20.56 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q2 2024.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 11.4% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2026 (growth of 113.8%); the low point was Q4 2023 (a decline of 87.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $101.9 million (Q1 2026), $108.54 million (Q4 2025) and $95.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Prokidney | 848.66 Mn | 1.96 Bn | - | 181.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181.56 Mn |
| Mar 31, 2026 | 101.90 Mn |
| Dec 31, 2025 | 108.54 Mn |
| Sep 30, 2025 | 95.32 Mn |
| Jun 30, 2025 | 84.94 Mn |
| Mar 31, 2025 | 97.81 Mn |
| Dec 31, 2024 | 99.12 Mn |
| Sep 30, 2024 | 108.09 Mn |
| Jun 30, 2024 | 214.51 Mn |
| Mar 31, 2024 | 84.39 Mn |
| Dec 31, 2023 | 60.65 Mn |
| Sep 30, 2023 | 191.39 Mn |
| Jun 30, 2023 | 243.55 Mn |
| Mar 31, 2023 | 271.64 Mn |
| Dec 31, 2022 | 490.25 Mn |
| Sep 30, 2022 | 506.33 Mn |
| Dec 31, 2021 | 20.56 Mn |
API Access
Prokidney Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PROK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PROK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PROK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();